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A practically useful measure of quality of life should be simple and quick to complete. A shortened Chinese version of the Functional
Living Index – Cancer (FLIC) was recently proposed and was called Quick-FLIC. This study aims to assess the measurement
properties of the Quick-FLIC. A total of 190 patients who received care from the National Cancer Centre of Singapore completed a
questionnaire package at baseline. Patients filled in a retest questionnaire on average 2 weeks after baseline to assess test–retest
reliability and responsiveness to change. The Quick-FLIC scores correlated well with the Functional Assessment of Chronic Therapy –
General scores (r¼0.78). Patients with different treatment status, performance status and self-rated health had significantly different
Quick-FLIC scores in the expected directions (ANOVA; each Po0.001). Internal consistency (Cronbach’s alpha¼0.87) and 2-week
test–retest reliability (intraclass correlation¼0.81) were also satisfactory. The measure was responsive to changes in health status
(Po0.001). The Quick-FLIC is a valid and reliable measure of health-related quality of life of cancer patients. The shortening of
established health-related quality of life instruments should be considered in order to reduce the burden of having patients to answer
lengthy questionnaires.
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For a health-related quality of life (HRQoL) measure to be
clinically useful, it should be simple and quick to complete
(Higginson and Carr, 2001). However, exisiting HRQoL ques-
tionnaires often include tens of items, which impose a burden on
the part of patients and risk undermining response rate and data
quality. In reviewing the problems in the assessment of HRQoL of
cancer patients, Ballatori (2001) suggested that simpler HRQoL
questionnaires that can be filled out in a shorter period of time are
needed.
The concept of shortening a measurement scale with multiple
(correlated) items by excluding less informative items is not new.
It has been practised in the educational, psychological and, to a
lesser extend, health research field (Coste et al, 1997). Ware et al
(1996) successfully streamlined a generic quality of life measure –
the Short Form 36 Health Survey – from 36 items to 12 items. Anne
Moran et al (2001) developed a short version of the Chronic
Respiratory Questionnaire without compromising the Question-
naire’s measurement properties appreciably. A 12-item version of
the General Health Questionnaire was developed from its longer
parent versions, and was valued as a more usable measure in the
older and frail populations (Cheung, 2002).
Although cancer researchers have repeatedly called for shorter
HRQoL measurement scales (Bernhard et al, 1998; Ballatori, 2001;
Gunnars et al, 2001), the shortening of HRQoL measure has
received limited attention in the oncology field. A recent article
proposed a shortened version of the Chinese version of the
Functional Living Index – Cancer (FLIC) (Schipper et al, 1984; Goh
et al, 1996), which is called Quick-FLIC (Cheung et al, 2003).
Briefly, the cross-sectional study employed factor analysis to
extract the most informative items from the Chinese version of the
FLIC. A total of 11 items were selected to form the short measure:
three related to physical well-being (‘feel well’, ‘pain or discomfort’
and ‘feel uncomfortable’), two related to each of the psychological
(‘discouraged’ and ‘frightened of the future’), symptoms (‘nausea’
and ‘pain related to illness’), family (‘hardship on those closest to
you’ and ‘satisfaction with work/housework’) and social aspects
(‘willing to see friends’, and ‘willing to see those closest to you’).
The score of each item ranged between 1 to 7. The sum of item
scores was scaled to the 0–100 range to give a Quick-FLIC score
(Fairclough, 2002, p.36)). The Quick-FLIC was compared with the
original FLIC and the Functional Assessment of Cancer Therapy –
General (FACT-G) (Cella et al, 1993) in the cross-sectional survey.
It was found that the three measures have similar psychometric
properties and they behaved similarly in relation to clinical
variables. However, the study had two major limitations. Firstly,
the Quick-FLIC was not employed as an individual measure.
Instead, the original, 22-item FLIC was used and the subset of 11
items was identified from it. So the validity of the Quick-FLIC
could have been elevated by a context effect. Secondly, the measure
has not been tested in a longitudinal setting. The previous
evaluation of this short measure was therefore incomplete. In this
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change of this new instrument, and discuss the value of the
shortening of HRQoL instruments for oncology studies.
MATERIALS AND METHODS
Patients
From September 2002 to January 2003, patients who attended the
outpatient clinic of the National Cancer Centre Singapore, as well
as in-patients under the care of the Centre’s department of
palliative care, were recruited into the study. Patients were
screened by the oncologists with the following inclusion criteria:
able to understand written Chinese and speak Mandarin (the
official Chinese language in Singapore), aged 18 years or older and
physically fit to self-administer a questionnaire. Patients with
evidence of brain metastasis, psychosis or severe depression were
excluded. The study was approved by the Ethics Committee of the
National Cancer Centre, Singapore.
Design and procedure
Patients who passed the inclusion/exclusion criteria aforemen-
tioned were referred to a research coordinator who explained the
study in detail, obtained informed consent, and delivered the
baseline questionnaires. Patients self-administered and returned
the questionnaires on the spot. The questionnaire package
included the Quick-FLIC and the Chinese versions of FACT-G, as
well as questions on marital status, education level and self-rated
health. Self-rated health, which was known to be a powerful
indictor of physical health and mortality (Cox et al, 1993), was
measured on a five-point scale ranging from ‘very good’ to ‘very
poor’. The median time to complete the baseline questionnaire
package was 14min. Karnofsky performance score, treatment
status and some other clinical information were rated by the
referring oncologists. At 1 week after the baseline, questionnaires,
which consisted of the Quick-FLIC and some other health-related
questions, were posted to the patients, together with a postage-
paid envelope for returning it. Change in health status was
measured on a five-point scale ranging from ‘much better’ to
‘much worse’. Patients were also asked whether they received
chemotherapy, radiotherapy or pain medication since the baseline
interview. The questionnaires included a question on the actual
date the patients filled in the questionnaires. If the patients did not
return the questionnaire after 2 weeks of the mailing, the research
coordinator would gave them a telephone reminder. In addition,
for patients who had a Karnofsky performance status below 80 at
baseline and for in-patients, the research coordinator attempted to
deliver the second questionnaire to them personally if they visited
or remained at the location of care in the period from 1 to 2 weeks
after the baseline. This extra effort was made because we expected
that these patients might have a lower probability of responding to
a questionnaire survey (Fairclough, 2002, pp.76–77).
The sample size planning considered several aspects of
measurement properties. It turned out that the issue of respon-
siveness to change required the largest number of participants. To
detect a change of 0.25 standard deviation in the pre- and post-test
difference in Quick-FLIC scores in relation to a difference of one
point on a five-point scale of change in health status, a sample size
of 130 is required to achieve a power of 0.80 and an alpha of 0.05
(nQuery Advisor software, Elashoff, 2000). Assuming that 70% of
patients who participated in the baseline study will return the
retest questionnaire, a total sample size of 190 was required.
Analysis
Missing values in the Quick-FLIC and FACT-G were imputed by
the half-rule (Cella, 1997; Fairclough, 2002, p. 37). The character-
istics of patients who provided complete and incomplete data were
compared using Fisher’s exact test since the latter group involved
only a small number of people. Validity was examined by
correlation analysis between Quick-FLIC and FACT-G, and by
analysis of variance (ANOVA) of Quick-FLIC scores by categories
of health and treatment variables. The ANOVA compared
differences in mean Quick-FLIC values between groups of
participants with different clinical characteristics, such as patients
with or without present evidence of disease. A significant
difference in mean values (Po0.05) was considered evidence for
known-group validity. Although the ANOVA technique involves
assumptions like normal distribution, it is robust to the violation
of assumptions, especially when sample size is large (Rice, 1995).
Education is often found to be a powerful predictor of general
health and psychological well-being (Cox et al, 1993; Cheung,
2002). If Quick-FLIC specifically measures the impact of cancer
and cancer treatment, it should not be strongly associated with this
variable. Analysis of variance was used for this educational
comparison. Reliability in terms of Cronbach’s alpha was
estimated in both the baseline and retest. Test–retest reliability
was estimated by intraclass correlation. One estimate was limited
to participants who filled in the retest questionnaire within 2 weeks
from baseline, and one was limited to participants who rated
themselves as having no change in health. There is no consensus
on how to measure responsiveness to change and whether the
change score, that is retest score minus baseline score, is a useful
index. In particular, it has been suggested that the ‘residual gain
score’, that is the actual retest score minus the retest score
predicted by baseline score, is a better indicator of change (Senn,
1997; Streiner and Norman, 1989, pp. 133–134). To give a more
comprehensive view, we investigated both residual gain scores and
change scores in relation to change in health status by ANOVA and
least-square test for trend. We compared those who received active
treatment following baseline assessment with those who did not
using ANOVA. Patients with a decline in health and patients who
received active treatment since baseline were expected to have a
larger decline in Quick-FLIC scores.
RESULTS
Patient characteristics
A total of 220 eligible patients were approached. In all, 17 of them
refused to participate, 10 filled in about half of the questionnaires
and then withdrew (four saying that it was too tiring); three left
more missing values than computable by the half-rule. As such,
there were 190 successfully completed questionnaires and 13
incomplete questionnaires.
Table 1 gives a summary of patients’ characteristics at baseline.
About half of the 190 patients were female; the mean age was 55
years. In total, 54% of the participants were under surveillance;
57% had no present evidence of disease. The distribution of
performance status more concentrated on 90 (46%) and 100 (26%),
but it spread over a wide range. As the number of participants with
Karnofsky score below 60 was small (n¼11, 6%), they were
grouped into a single category. Most of the participants were
outpatients. About 40% rated their health as average. Profile of the
13 patients with incomplete information was also given in Table 1.
Percentages are not given as they are unstable when the number of
observation is small. Those who did not fully complete the
questionnaires were more likely to have lower performance status
(P¼0.003), on active treatment (P¼0.043), and be in-patients
(P¼0.001).
Descriptive statistics
Table 2 provides the descriptive information of the Quick-FLIC
and its individual items, which were recoded so that a high score
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scores was 76.3 (18.4). A large range of the Quick-FLIC scale was
actually utilised, the minimum and maximum being 13.6 and 100,
respectively. The individual items were more skewed, with up to
79% of participants reaching the ceiling value of one item (how
much nausea?).
Validity
The Quick-FLIC was highly correlated with FACT-G, with
Pearson’s correlation coefficient (r) being 0.78. (95% CI¼0.71–
0.83). Figures 1 and 2 plot the Quick-FLIC scores in relation to
Karnofsky performance score and self-rated health status. Both
show a significant decrease in HRQoL as performance or health
status declined (ANOVA; each Po0.001). In addition, as shown in
Table 3, patients with present evidence of disease and patients
receiving active treatment had significantly lower scores (each
Po0.001). There was no significant difference in Quick-FLIC
scores between educational groups (P40.05).
Responsiveness to change
Table 4 shows the residual gain scores by changes in health status
since baseline interview. Those who reported better or much better
health had a Quick-FLIC score in the retest 2.9 and 5.1 points
higher than predicted by their baseline scores; those whose health
became worse or much worse had scores 10.2 and 18.5 points
lower than predicted. The difference in residual gain score was
more obvious in the lower range of change in health status than in
the upper range, but a test for nonlinearity failed to show
significance (P40.05). A test for linear trend shows that for each
step of decline in health status, the Quick-FLIC residual gain score
decreased by 6.3 points (Po0.001). Furthermore, patients who did
Table 1 Patient characteristics
Completed questionnaire (n¼190)Incomplete questionnaire (n¼13)
Variable Category Frequency Percentage Frequency
Gender Female 99 52.1 7
Male 91 47.9 6
Age (mean) 55 63
Education Primary incomplete 52 27.4 8
Primary complete 64 33.7 2
Secondary 59 31.1 3
Postsecondary 15 7.9 0
Tumour type Breast 62 32.6 4
Colorectal 35 18.4 2
Lung 29 15.3 2
Head and neck 35 18.4 3
Others 29 15.2 2
Karnofsky score 100 49 25.8 1
90 87 45.8 2
80 24 12.6 5
60–70 19 10.0 2
30–50 11 5.8 3
Treatment status Active treatment 87 45.8 10
Surveillance 103 54.2 3
Presence of diseaseYes 81 42.9 12
No 108 57.1 1
Type of care Outpatient 178 93.7 6
In-patient 12 6.3 7
Self-rated health Very good 32 16.8 0
Good 56 28.5 2
Average 77 40.5 5
Poor 14 7.4 3
Very poor 11 5.8 2
Table 2 Descriptive summary of quick-FLIC
N Mean s.d. % at ceiling
Quick-FLIC score 190 76.3 18.4 5
Individual items
a
1. Feel well 190 5.2 1.4 22
2. Hardship to those closed to you 190 5.6 1.9 51
3. Discourage 190 5.7 1.6 46
4. Satisfaction with work/housework 188 5.2 1.7 31
5. Feel uncomfortable 190 5.8 1.6 54
6. Pain or discomfort affects activities 190 5.3 1.9 39
7. Willing to see those closest to you 189 6.2 1.3 63
8. How much nausea 190 6.5 1.2 79
9. Frightened of the future 190 5.8 1.7 52
10. Willing to see friends 187 5.7 1.6 49
11. Pain or discomfort 189 4.4 2.4 35
aAll items recoded to the direction of a higher score indicates a better quality of life.
Scores on individual items ranged from 1 to 7; combined Quick-FLIC score scaled to
range from 0 to 100.
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lnot receive active treatment since baseline had a mean residual
gain score of 2.6 points higher than expected, while those who did
had a mean of  4.3 points (P¼0.001). Analysis of change score
showed a similar pattern of responsiveness. A test for linear trend
shows that for each step of decline in health status, the change
score decreased by 3.7 points (Po0.001). The difference in change
scores between groups with different postbaseline treatment status
was marginally significant (P¼0.052).
Reliability
In all, 84% of the participants returned the retest questionnaires
(n¼160). Cronbach’s alpha was 0.87 (95% CI¼0.84–0.90) in the
baseline and 0.88 (0.85–0.90) in the retest. The median interval
from baseline to filling in the retest questionnaire was 14 days. The
first and third quartiles were 10 and 21 days, respectively. Among
participants who completed the retest within 14 days (n¼91), the
test–retest reliability was 0.81 (95% CI¼0.73–0.88). Among
patients who reported ‘the same’ health status (n¼56) in the
retest, the reliability was 0.78 (0.67–0.88). We also explored the
test–retest reliability in patients who reported ‘much better’,
‘better’, ‘worse’ and ‘much worse’ health status. The coefficients
were, respectively, 0.54, 0.77, 0.51 and 0.00 (The last one was
truncated at zero since the error variance was larger than the
between-patients variance [Fayers and Machin, 2000]).
DISCUSSION
Despite substantial development in quality of life research in the
last two decades, practical problems remain to be solved. It has
been suggested that the use of shorter instead of longer HRQoL
questionnaires might mitigate the problems of patients’ inability/
unwillingness to complete a questionnaire because of poor health
and reduce missing values during follow-up (Bernhard et al, 1998;
Axelsson and Sjoden, 1999; Ballatori, 2001; Higginson and Carr,
2001). In our study, it was also patients who were frailer who
tended to provide incomplete questionnaire information. Some
previous studies have demonstrated the practicability of reducing
the number of items in composite measurement scales by 60–70%
(Ware et al, 1996; Anne Moran et al, 2001). Although relatively
common in other areas of research and services, the shortening of
existing HRQoL measures in oncology has not received much
attention.
A recent cross-sectional study proposed a short version of FLIC.
The present study has formally evaluated its properties and found
it satisfactory in various aspects. Nevertheless, the present study
was not designed to show the practical advantages of using a short
or shortened HRQoL measure vs a long or original one. So, for
instance, we cannot answer whether using a shorter instrument
would indeed give fewer missing values. Another limitation was
that the number of patients who reported a decline in health status
in the retest was relatively small, and the change in health status
variable was based on self-assessment. Further studies with a larger
number of respondents in the lower range of changes in health and
with objectively assessed changes in health status would be helpful.
Some individual items were quite skewed; one of them having 79%
of participants at the ceiling value. This is a quite common
phenomenon in quality of life assessment. Streiner and Norman
(1989, p. 44) recommended that items with 80% or more
respondents endorsing one category should be excluded from a
composite scale. The Quick-FLIC items did not exceed this level
and their distributions did not appear to be more concentrated
than other cancer HRQoL measures’ (eg Basen-Engquist et al,
2001). However, we do not recommend using a few skewed items
to assess subdomains of HRQoL; we use all the 11 items to assess
overall HRQoL. In order to improve response rate to the retest
questionnaire, we made an effort to deliver the retest questionnaire
to the patients personally rather than by post if they had poor
performance status or if they were in-patients at baseline. Without
doing a randomised comparison, we cannot tell how successful the
extra effort was on response rate. However, the procedure should
not affect the measurement properties shown here, as the retest
data was not evaluated in relation to baseline clinical character-
istics.
The correlation between Quick-FLIC and FACT-G (r¼0.78) in
this study was very similar to that between FLIC and FACT-G
(r¼0.79) in a large-scale study that used the FLIC to validate the
FACT-G (Cella et al, 1993), giving support to the concurrent
validity of Quick-FLIC. Furthermore, trends of Quick-FLIC score
in relation to health status assessed by patients and performance
status assessed by clinicians were clearly seen. Its known-group
validity was supported by its ability to clearly differentiate patients
with different treatment and disease status. That it did not relate to
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Figure 1 Box-whisker plot of Quick-FLIC scores by Karnofsky
performance status.
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Figure 2 Box-whisker plot of Quick-FLIC scores by self-rated health
status.
Table 3 Mean (s.d.) of quick-FLIC scores by patient characteristics
Present
evidence of
disease
Receiving
active
treatment
Secondary
education or
higher
No 83.2 (14.7) 84.1 (14.1) 76.5 (18.3)
Yes 67.4 (19.2) 67.2 (18.8) 76.1 (18.8)
P-value (ANOVA) o0.001 o0.001 0.889
Quick-FLIC
Y-B Cheung et al
1750
British Journal of Cancer (2004) 90(9), 1747–1752 & 2004 Cancer Research UK
C
l
i
n
i
c
a
leducation suggested the Quick-FLIC measured HRQoL that was
quite specific to cancer-related problems rather than general health
or well-being. It was suggested that a measurement scale should
have a test–retest reliability of 0.75 or above (Streiner and
Norman, 1989, p. 90). Quick-FLIC passed this standard and its
reliability in terms of Cronbach’s alpha was high. Both residual
gain score and change score showed its responsiveness to change
in health status. Postbaseline treatment status was also reflected in
the change in residual gain scores.
Change in health was positively related to baseline health status.
For instance, a large proportion of participants in the ‘much better’
(77%) and ‘better’ (43%) groups had rated their health as either
‘good’ or ‘very good’ in the baseline interview and they had high
baseline Quick-FLIC scores. As there was not much room to
improve on the Quick-FLIC scale for these participants, the means
of change scores were close to zero rather than showing a positive
change. This is a ceiling effect that may suppress an indication of
improvement among well patients. Furthermore, test–retest
reliability was higher among participants who had ‘much better’
health status in the follow-up survey than those who had ‘much
worse’ (0.54 vs 0.00). Similarly, it was higher among participants
who had ‘better’ health status than those who had ‘worse’ (0.77 vs
0.51). This again indicated a ceiling effect. In light of it, analysis of
residual gain score is more suitable than analysis of change score
in the assessment of changes in HRQoL in patients who are quite
well at baseline (Senn, 1997; Streiner and Norman, 1989, pp. 133–
134). Cancer research often examines the changes in HRQoL of
patients with symptoms and/or under therapy at baseline, rather
than patients without symptoms or patients who are under
surveillance only. So this ceiling effect should not have a big
practical impact on the applications of the Quick-FLIC.
Ethnic Chinese people reside in many regions of the world. In
Singapore and China, they use the simplified form of Chinese
characters. The Quick-FLIC needs to be changed into the
conventional form of characters before use in areas like Hong
Kong and Taiwan. This is a simple task since most Chinese word-
processing programmes allow users to choose the type of
characters. However, due to differences in factors such as literacy
level, further studies outside Singapore are required before the
usefulness of the Quick-FLIC in these regions can be assured. One
of the present authors translated the English FLIC into Chinese and
Malay (Goh et al, 1996). The Chinese FLIC forms the basis of the
present work. So there is no need to repeat the translation process
to develop English and Malay versions of the Quick-FLIC. We can
simply take the corresponding items from the English and Malay
version of FLIC. However, the resultant short questionnaires
should be subject to validation again in English- and Malay-
speaking populations.
Even though only half of the 22 items of the original FLIC are
included to form the Quick-FLIC, we have found it to have
sufficient validity, reliability and sensitivity as a measure of overall
health-related quality–of life measurement scale for use in
oncology. In this case, the idea of shortening an existing well-
established HRQoL measurement scale appears to be useful. The
advantages of using short instruments may include: less burden on
the part of patients, fewer missing values and/or incomplete
questionnaires, higher willingness to participate. While the first
advantage seems to be definitional and worthy in its own sake,
evidence supporting the latter two claims is scanty and the present
study does not provide such evidence either. In summary, we have
found the Quick-FLIC a satisfactory measure of health-related
quality –of life of cancer patients. We recommend further research
on the practical advantages of using this and other short
instruments in comparison with longer HRQoL instruments.
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